{
  "main_header": {
    "sid": 764862,
    "name": "Sandu Pharma.",
    "stock_name": "Sandu Pharma.",
    "full_name": "Sandu Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sandu-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "42.22",
    "chg": -0.68,
    "chgp": "-1.59%",
    "dir": -1,
    "prev_price": "42.90",
    "mcapval": "41.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524703,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE751D01014",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "712 ",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/sandu-pharma-764862-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 78,
    "sid": "764862",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/sandu-pharmaceuticals-764862"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Jun-2026",
      "details": "Newspaper Publication for opening of special window for re lodgment of transfer requests for physical shares and Second 100 days campaign Saksham Niveshak creating awareness amongst shareholders to update KYC Details and for shareholders engagement to prevent transfer of unpaid/unclaimed dividends to investor Education and Protection Fund (IEPF)",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "18-May-2026",
      "details": "Annual Secretarial Compliance Report for Year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Board to consider Dividend",
      "datetime": "27-Apr-2026",
      "details": "Board to consider Final Dividend if any subject to approval of the Shareholders in forthcoming Annual General Meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sandu Pharmaceuticals Ltd has declared <strong>8%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News